What Does The Alzheimer's Association Say About Medical Cannabis? | cannabisMD

What Does The Alzheimer’s Association Say About Medical Cannabis?

Alzheimer’s Association and Medical Cannabis

There has been a lot of talk in recent times about the potential uses of medical cannabis for alzheimer’s disease. This disease is without a doubt one of the most distressing there is. For both the patient and their loved ones, it can be torturous to endure. And with no real hope for a cure on the horizon, it’s no wonder they cling to any hope there may be. Certainly, there is some evidence to suggest that medical cannabis could become a treatment option for enhancing the care of alzheimer’s patients, but what does The Alzheimer’s Association have to say about it all?

In 1980 The Alzheimer’s Association was founded. Since then it has been working tirelessly to advocate and spread awareness of the disease, support and accelerate research into the disease and possible treatments and cures, and provided much needed care and support to those affected by the disease. It is a great example of what a health organization can achieve.

Their mission is to “eliminate Alzheimer’s Disease through the advancement of research; to provide and enhance care and support for all affected; and to reduce the risk of dementia through the promotion of brain health.”

The organization, who’s national office is located in Chicago, hasn’t got much to say about cannabis. They remain fairly factual and share research with a very balanced viewpoint. Keith Fargo, director of scientific programs and outreach for The Alzheimer’s Association, has described medical cannabis as a “legitimate avenue of research” which is a clear statement in favor of further research.

It’s not surprising that the Association doesn’t say much more about medical cannabis, as it has a responsibility to its users and to society to remain factual and not to engage in fads or trends. For now, the actual hard scientific research into the use of medical cannabis for alzheimer’s disease is extremely sparse. For the Association or it’s staff to come out strongly in favour of a treatment that remains untested would be totally unethical and irresponsible.

For now, it’s encouraging to see that they support the prospect of conducting more studies into the potential uses of medical cannabis in treatments for alzheimer’s disease, but until those studies take place it’s unlikely that they will say much more on the issue.

Read more about why cannabis treatments are at the forefront of the fight against alzheimer’s.

Leave a Reply

Your email address will not be published. Required fields are marked *